A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors

Detalles Bibliográficos
Autores principales: Papadopoulos, Kyriakos P, Tsai, Frank, Hamid, Omid, Xiao, Feng, Steele, Keith E, Rebelatto, Marlon C, Robbins, Paul B, Karakunnel, Joyson J, Lai, Dominic W, Mahipal, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645453/
http://dx.doi.org/10.1186/2051-1426-3-S2-P165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645453/
http://dx.doi.org/10.1186/2051-1426-3-S2-P165

Ejemplares similares